Search

everythinglearnresearchcommunity

for

Search:↓

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Inflammasome proteins may help diagnose and treat Parkinson's disease.

MicroRNAs and AI can improve cashmere goat hair quality and aid in hair disorder diagnosis.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Pityriasis rubra pilaris can occur with myasthenia gravis.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Managing multiple autoimmune diseases in one patient is extremely challenging.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Meibomian glands are highly specialized and differ significantly from other sebaceous glands in structure and function.

Alopecia areata patients have a higher risk of other immune-related diseases.

AMT may be more effective than finasteride for hair growth in androgenetic alopecia.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Androgenetic alopecia in women may be improved by targeting oxidative stress, inflammation, and fibrosis.

Special cells can help regrow hair in alopecia areata.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Mouse models help understand alopecia areata and find treatments.

AGA patients have higher insulin resistance and serum progranulin levels, suggesting a link to metabolic issues.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

The 2012 criteria are better for diagnosing atypical lupus cases.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.